In this cross-sectional study of 1144 participants, including individuals with and without cognitive impairment, higher levels of PA were significantly associated with lower levels of plasma neurofilament light chain and phosphorylated tau-217 and better cognition. This evidence concerns the gene MAPT and Cognitive impairment.